抗MDA5抗体阳性皮肌炎中耶氏肺孢子菌肺炎的高患病率与高死亡率
研究纳入91例抗MDA5抗体阳性皮肌炎患者,其中44例为耶氏肺孢子菌肺炎(PJP)阳性,检出率48.4%。发热和乳酸脱氢酶升高是PJP发生的独立危险因素,TMP/SMZ预防是独立保护因素;mNGS诊断PJP的灵敏度100.0%、特异度90.0%。
要点
- 抗MDA5抗体阳性皮肌炎患者PJP检出率48.4%,68.2%发生在病程前3个月。
- 发热和乳酸脱氢酶升高是PJP发生的独立危险因素,TMP/SMZ预防是独立保护因素。
- mNGS诊断PJP灵敏度100.0%、特异度90.0%,曲线下面积0.95。
核心结论
- PJP在抗MDA5抗体阳性皮肌炎中患病率和死亡率均高,识别高危患者并及时启用TMP/SMZ预防至关重要。
- 当怀疑PJP时,mNGS是抗MDA5抗体阳性皮肌炎病原体检测的首选方法。
研究设计与样本
- 研究纳入接受mNGS或实时PCR检测PJP的抗MDA5抗体阳性皮肌炎患者,共91例,其中44例归入PJP阳性组。
- 采用Logistic回归分析PJP发生的潜在危险因素,采用Cox比例风险回归分析死亡的危险因素,并比较mNGS与传统方法的诊断效能。
主要发现
- PJP检出率为48.4%,68.2%的PJP发生在病程前3个月,该时期死亡率最高(20.5%)。
- 发热和乳酸脱氢酶升高是PJP发生的独立危险因素,TMP/SMZ预防是独立保护因素(均P < 0.05)。
- 高龄和乳酸脱氢酶升高是抗MDA5抗体阳性皮肌炎合并PJP患者死亡的预测因素(均P < 0.05)。
- mNGS诊断PJP的灵敏度为100.0%,特异度为90.0%,曲线下面积最高为0.95(P < 0.001)。
关键数值与推荐
- PJP检出率48.4%(44/91例)。
- PJP发生独立危险因素:发热和乳酸脱氢酶升高(均P < 0.05)。
- PJP发生独立保护因素:TMP/SMZ预防(P < 0.05)。
- 死亡预测因素:高龄和乳酸脱氢酶升高(均P < 0.05)。
- mNGS诊断PJP:灵敏度100.0%,特异度90.0%,曲线下面积0.95(P < 0.001)。
临床怎么用
- 作者认为,临床医生识别高危患者并及时启用TMP/SMZ预防PJP至关重要。
- 作者认为,当怀疑PJP时,mNGS是抗MDA5抗体阳性皮肌炎病原体检测的首选方法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To identify potential risk factors and prognostic factors of Pneumocystis jirovecii pneumonia (PJP) infection in anti-melanoma differentiation-associated gene 5 antibody-positive DM (anti-MDA5+ DM) patients, and to evaluate the diagnostic performance of metagenomic next-generation sequencing (mNGS). METHODS: Anti-MDA5+ DM patients who underwent mNGS or real-time PCR for PJP detection were recruited. The potential risk factors for PJP occurrence and death were analysed via Logistic regression and Cox proportional hazards regression, respectively. The diagnostic efficacy of mNGS was compared with the conventional methods. RESULTS: 91 patients were enrolled and 44 were assigned to PJP+ group. The PJP detection rate was 48.4%. PJP often occurred in the first 3 months (68.2%) of the disease; this period also showed the highest mortality rate (20.5%). Fever and increased lactate dehydrogenase (LDH) were independent risk factors for PJP occurrence, while trimethoprim-sulfamethoxazole (TMP/SMZ) prophylaxis was an independent protective factor (all P < 0.05). Older age and increased LDH were predictors for mortality in patients with anti-MDA5+ DM and PJP (all P < 0.05). In addition, we found that mNGS had a sensitivity of 100.0% and specificity of 90.0% in diagnosing PJP, with the highest area under the curve of 0.95 (P < 0.001). CONCLUSION: PJP has high prevalence and mortality in anti-MDA5+ DM. It is crucial for clinicians to identify high-risk patients and promptly institute TMP/SMZ to prevent PJP. mNGS is the preferred approach for pathogen detection in anti-MDA5+ DM when PJP is suspected.
引用
- Chen X, Shu X, He L, et al. High prevalence and mortality of Pneumocystis jirovecii pneumonia in anti-MDA5 antibody-positive dermatomyositis. Rheumatology (Oxford). 2023. PMID: 36734589. doi:10.1093/rheumatology/kead063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。